FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Atropine Sulfate Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Anesthesia; Neurology; Pediatric

Expand all

American Regent/Luitpold (Reverified 05/19/2021)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25) Available American Regent is currently releasing the 1mg/mL, 1 mL vial, (NDC 00517-1010-25) Other
0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25) Available American Regent is currently releasing the 0.4mg/mL, 1 mL vial, NDC 00517-0401-25 Other

Amphastar Pharmaceuticals, Inc./IMS (Reverified 07/09/2021)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3340-1) Available

Fresenius Kabi USA, LLC (Revised 07/22/2021)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20) 9 month expiry (4/2022 expiry) dating available by request. Check wholesaler inventory Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 07/06/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.4 mg/mL, 20 mL vial (NDC 0641-6006-10) This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing in the July - August 2021 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Revised 07/27/2021)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe (NDC 0409-1630-10) Limited Supply Available. Next Delivery: September 2021; Estimated Recovery: October 2021

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages


Dear Valued Customer Emergency Syringe Update Letter
Demand increase for the drug
0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe (NDC 0409-9630-05) Available
Dear Valued Customer Emergency Syringe Update Letter
Other
0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34) Limited Supply Available. Next Delivery and Estimated Recovery: September 2021

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages


Dear Valued Customer Emergency Syringe Update Letter
Demand increase for the drug
1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34, pack of 10; NDC 0409-4911-11, individual) Next Delivery: September 2021; Estimated Recovery: October 2021

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages


Dear Valued Customer Emergency Syringe Update Letter
Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English